• Mashup Score: 5

    Access this Symposium on Clinical chaired by Professor J. Merino (Spain,ES),Doctor D. Packer (United States of America,US).

    Tweet Tweets with this article
    • 20 years of pioneering in EP. Free access on #ESC365 Watch now for an overview of 20 years of innovation in EP. See what the future holds for atrial fibrillation mapping/ablation & in supraventricular/ventricular tachycardia ablation https://t.co/QBIvpk6Art #EHRA2023 #EHRA_ESC https://t.co/I5MeWUHvBV

  • Mashup Score: 0

    In a real-world population, pulsed field ablation using a novel catheter was safe for most patients with atrial fibrillation in routine practice, with 78% free from AF at 1 year, registry data show. Pulsed field ablation (PFA) is a novel AF ablation modality that has demonstrated preferential tissue ablation with no esophageal damage in early clinical trials, Vivek Y. Reddy, MD, director of

    Tweet Tweets with this article
    • In a real-world population, pulsed field ablation using a novel catheter was safe for most patients with atrial fibrillation in routine practice, with 78% free from AF at 1 year @VivekReddyMD @MountSinaiNYC #AFib #EHRA2023 #EPeeps #EHRA_ESC #cardiotwitter https://t.co/i7MkGgosod

  • Mashup Score: 0

    The novel ANTWERP score demonstrated good predictive value in identifying patients whose heart failure symptoms would improve after ablation for atrial fibrillation, a speaker reported.The score utilized readily available clinical values including QRS width, known etiology, AF subtype and atrial dilation to identify those who may experience improved left ventricular ejection fraction after AF

    Tweet Tweets with this article
    • ICYMI: “The ANTWERP score was developed to predict the response to ablation in heart failure patients with impaired (below 50%) ejection fraction.” #AFib #EHRA2023 #EPeeps #EHRA_ESC #cardiotwitter https://t.co/QbapWrLJqs

  • Mashup Score: 0

    In a small, single-center trial, the novel Marshall-Plan ablation strategy improved 10-month arrhythmia recurrence compared with pulmonary vein isolation alone for persistent atrial fibrillation, a speaker reported.“After 10 months of follow up, the success rate in the Marshall-Plan group was significantly better (87%) compared to the PVI only group (70%),” Nicolas Derval, MD, head of

    Tweet Tweets with this article
    • ICYMI: “After 10 months of follow up, the success rate in the Marshall-Plan group was significantly better (87%) compared to the PVI only group (70%),” #AFib #EHRA2023 #EPeeps #EHRA_ESC https://t.co/Fxvrd9WrE4

  • Mashup Score: 0

    The novel ANTWERP score demonstrated good predictive value in identifying patients whose heart failure symptoms would improve after ablation for atrial fibrillation, a speaker reported.The score utilized readily available clinical values including QRS width, known etiology, AF subtype and atrial dilation to identify those who may experience improved left ventricular ejection fraction after AF

    Tweet Tweets with this article
    • ICYMI: “The ANTWERP score was developed to predict the response to ablation in heart failure patients with impaired (below 50%) ejection fraction.” #AFib #EHRA2023 #EPeeps #EHRA_ESC #cardiotwitter https://t.co/QbapWrLJqs

  • Mashup Score: 0

    In a small, single-center trial, the novel Marshall-Plan ablation strategy improved 10-month arrhythmia recurrence compared with pulmonary vein isolation alone for persistent atrial fibrillation, a speaker reported.“After 10 months of follow up, the success rate in the Marshall-Plan group was significantly better (87%) compared to the PVI only group (70%),” Nicolas Derval, MD, head of

    Tweet Tweets with this article
    • ICYMI: “After 10 months of follow up, the success rate in the Marshall-Plan group was significantly better (87%) compared to the PVI only group (70%),” #AFib #EHRA2023 #EPeeps #EHRA_ESC https://t.co/Fxvrd9WrE4

  • Mashup Score: 1

    In a small, single-center trial, the novel Marshall-Plan ablation strategy improved 10-month arrhythmia recurrence compared with pulmonary vein isolation alone for persistent atrial fibrillation, a speaker reported.“After 10 months of follow up, the success rate in the Marshall-Plan group was significantly better (87%) compared to the PVI only group (70%),” Nicolas Derval, MD, head of

    Tweet Tweets with this article
    • In a small, single-center trial, the novel Marshall-Plan ablation strategy improved 10-month arrhythmia recurrence compared with pulmonary vein isolation alone for persistent #AFib #EHRA2023 #EPeeps #EHRA_ESC https://t.co/Fxvrd9WZtC

  • Mashup Score: 1

    The novel ANTWERP score demonstrated good predictive value in identifying patients whose heart failure symptoms would improve after ablation for atrial fibrillation, a speaker reported.The score utilized readily available clinical values including QRS width, known etiology, AF subtype and atrial dilation to identify those who may experience improved left ventricular ejection fraction after AF

    Tweet Tweets with this article
    • The novel ANTWERP score demonstrated good predictive value in identifying patients whose #HeartFailure symptoms would improve after ablation for #AFib #EHRA2023 #EPeeps #EHRA_ESC #cardiotwitter https://t.co/QbapWrMhg0

  • Mashup Score: 0

    Statin therapy may improve risk for stroke or transient ischemic attack among patients with atrial fibrillation compared with nonuse, regardless of concomitant anticoagulant use, a speaker reported.In addition, longer-duration statin use may further lower risk for stroke/TIA among patients with AF, according to data presented at the Annual Congress of the European Heart Rhythm Association.

    Tweet Tweets with this article
    • ICYMI: “These data support the use of statins to prevent stroke and transient ischemic attack in patients with new-onset atrial fibrillation,” @HKUniversity @healioneurology #EHRA2023 #EPeeps #EHRA_ESC #Cardiotwitter https://t.co/TrjuYOL1SP